OpenArc Corporate Advisory’s Strata Critical Medical Inc SRTA Stock Holding History

OpenArc Corporate Advisory’s Portfolio SRTA Stock Details SRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$55.7K	Buy	+10,901	New	+$59.4K	﹤0.01%	923

Other funds holding SRTA

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

CenterBook Partners Greenwich, Connecticut $2.18B AUM 12.5% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Ashton Thomas Private Wealth Scottsdale, Arizona $4.98B AUM 21.09% 1-Year Est. Return

Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

OpenArc Corporate Advisory's SRTA Position: Q3 2026 in Review

OpenArc Corporate Advisory opened a new position in Strata Critical Medical Inc (SRTA) in Q3 2026: 10,901 shares worth $55.7K. The stake represents ﹤0.01% of the portfolio and ranks #923 among its holdings.

53 funds tracked by Wall St. Rank hold SRTA as of Q3 2026.

OpenArc Corporate Advisory held 10,901 shares of Strata Critical Medical Inc worth $55.7K as of Q3 2026.
Strata Critical Medical Inc was a new OpenArc Corporate Advisory position in Q3 2026.
Strata Critical Medical Inc made up ﹤0.01% of OpenArc Corporate Advisory's portfolio in Q3 2026, its #923 holding.
53 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q3 2026.

Based on OpenArc Corporate Advisory's 13F filing for Q3 2026, filed 21 Oct 2026.